NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aprecia Pharmaceuticals

Aprecia Pharmaceuticals

Private
Mason, OhioHealthcare & Life Scienceshttps://aprecia.com/

Last Round

Debt

Jul 5, 2016

Total Funding Raised

$30M

Company Overview

Aprecia Pharmaceuticals is a pharmaceutical company that develops, manufactures, and markets fast-melt pharmaceutical products using advanced three-dimensional printing technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, 3D Printing, Pharma Supply Chain, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Infrastructure

Keywords

3D printed pillspharmaceutical 3D printingorally disintegrating tabletscontract development and manufacturing organizationCDMOdrug delivery platformfast-melt tabletsZipDoseadditive manufacturingswallowing difficultiesdysphagiahigh dose deliverybinder jet 3D printingsmart manufacturingagile pharmaceutical manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aprecia Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Aprecia Pharmaceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aprecia Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 5, 2016
VC RoundJan 27, 2016
VC RoundNov 11, 2011
View all Funding Rounds

Key People

Founding team and executive leadership

Kyle Smith

President Chief Operating Officer

Executive Team

Rob Williford

COO

Executive Team

Aprecia Pharmaceuticals Investors

Notable investors and investment history

Aprecia Pharmaceuticals investors
InvestorRounds
Hercules CapitalDebt
Deerfield ManagementVC Round
JW Asset ManagementVC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 72% MoM, reaching 2.8K.

  • Jul 5, 2016

    $30M round led by Hercules Capital

View all signals

Aprecia Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aprecia Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aprecia Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersMason, Ohio
Employee Range65
Year Founded2003
Last FundingJul 5, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.